Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Compare index fund performance year by year to detect stability, volatility, and opportunities for strategic adjustments.
25,004 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A practical comparison of Corning and QuantumScape for 2026. Learn where each stock shines, the risks you should watc...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
Three key ETFs are steering the reshoring trend in critical minerals as China tightens export controls. REMX, LIT, an...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
A niche gold strategy that pairs silver-like cash flow with gold exposure is gaining traction. IAUI offers about 12% ...
As CONY markets itself as a high-yield option income ETF, new performance data reveal a path that may worry long-term...
As the spot Bitcoin ETF field consolidates, IBIT and FBTC remain the leading contenders. Both own actual Bitcoin and ...
When a high-profile ad flares into a public family moment, it isn’t just entertainment. It’s a lesson in brand risk, ...
Bitcoin ETFs posted a sixth consecutive week of outflows as Franklin Templeton filed two new ETF proposals. Market wa...
BlackRock has rolled out a new Bitcoin ETF that promises premium income alongside crypto exposure. This analysis brea...